Diffusion of ofloxacin into cerebrospinal fluid of patients with purulent meningitis or ventriculitis. 1989

J C Pioget, and M Wolff, and E Singlas, and M J Laisne, and B Clair, and B Regnier, and F Vachon
Intensive Care Unit, Bichat-Claude-Bernard Hospital, Paris, France.

The penetration of ofloxacin was studied in 22 patients with purulent meningitis or ventriculitis treated with conventional antibiotics. Three successive doses of 200 mg were infused at 12-h intervals during the acute stage of the disease. Ten patients received three additional doses when the meninges were considered to be healed. Cerebrospinal fluid (CSF) was drawn 0.5, 3, 6, or 12 h after the last infusion. Serial plasma and CSF samples were also obtained from patients with ventricular drainage. Concentrations in CSF ranged from 0.96 +/- 0.15 to 1.80 +/- 0.29 microgram/ml, depending on sampling time. The percentage of penetration in ventricular fluid, expressed as the ratio of the CSF area under the curve from 0 to 12 h to the plasma area under the curve from 0 to 12 h, was 73 +/- 6. Ofloxacin readily diffuses into CSF of patients with meningitis or ventriculitis and may be useful for treatment of CSF infections caused by susceptible pathogens.

UI MeSH Term Description Entries
D008297 Male Males
D008581 Meningitis Inflammation of the coverings of the brain and/or spinal cord, which consist of the PIA MATER; ARACHNOID; and DURA MATER. Infections (viral, bacterial, and fungal) are the most common causes of this condition, but subarachnoid hemorrhage (HEMORRHAGES, SUBARACHNOID), chemical irritation (chemical MENINGITIS), granulomatous conditions, neoplastic conditions (CARCINOMATOUS MENINGITIS), and other inflammatory conditions may produce this syndrome. (From Joynt, Clinical Neurology, 1994, Ch24, p6) Pachymeningitis,Meningitides,Pachymeningitides
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002552 Cerebral Ventricles Four CSF-filled (see CEREBROSPINAL FLUID) cavities within the cerebral hemispheres (LATERAL VENTRICLES), in the midline (THIRD VENTRICLE) and within the PONS and MEDULLA OBLONGATA (FOURTH VENTRICLE). Foramen of Monro,Cerebral Ventricular System,Cerebral Ventricle,Cerebral Ventricular Systems,Monro Foramen,System, Cerebral Ventricular,Systems, Cerebral Ventricular,Ventricle, Cerebral,Ventricles, Cerebral,Ventricular System, Cerebral,Ventricular Systems, Cerebral
D004058 Diffusion The tendency of a gas or solute to pass from a point of higher pressure or concentration to a point of lower pressure or concentration and to distribute itself throughout the available space. Diffusion, especially FACILITATED DIFFUSION, is a major mechanism of BIOLOGICAL TRANSPORT. Diffusions
D004660 Encephalitis Inflammation of the BRAIN due to infection, autoimmune processes, toxins, and other conditions. Viral infections (see ENCEPHALITIS, VIRAL) are a relatively frequent cause of this condition. Inflammation, Brain,Rasmussen Syndrome,Brain Inflammation,Encephalitis, Rasmussen,Rasmussen Encephalitis,Rasmussen's Syndrome,Brain Inflammations
D005260 Female Females
D006207 Half-Life The time it takes for a substance (drug, radioactive nuclide, or other) to lose half of its pharmacologic, physiologic, or radiologic activity. Halflife,Half Life,Half-Lifes,Halflifes
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths

Related Publications

J C Pioget, and M Wolff, and E Singlas, and M J Laisne, and B Clair, and B Regnier, and F Vachon
January 1986, Infection,
J C Pioget, and M Wolff, and E Singlas, and M J Laisne, and B Clair, and B Regnier, and F Vachon
April 1992, The Journal of antimicrobial chemotherapy,
J C Pioget, and M Wolff, and E Singlas, and M J Laisne, and B Clair, and B Regnier, and F Vachon
May 1985, Pathologie-biologie,
J C Pioget, and M Wolff, and E Singlas, and M J Laisne, and B Clair, and B Regnier, and F Vachon
December 1984, Presse medicale (Paris, France : 1983),
J C Pioget, and M Wolff, and E Singlas, and M J Laisne, and B Clair, and B Regnier, and F Vachon
April 1980, Antimicrobial agents and chemotherapy,
J C Pioget, and M Wolff, and E Singlas, and M J Laisne, and B Clair, and B Regnier, and F Vachon
February 1984, Presse medicale (Paris, France : 1983),
J C Pioget, and M Wolff, and E Singlas, and M J Laisne, and B Clair, and B Regnier, and F Vachon
January 1983, Antimicrobial agents and chemotherapy,
J C Pioget, and M Wolff, and E Singlas, and M J Laisne, and B Clair, and B Regnier, and F Vachon
July 1985, Antimicrobial agents and chemotherapy,
J C Pioget, and M Wolff, and E Singlas, and M J Laisne, and B Clair, and B Regnier, and F Vachon
August 1988, The Journal of antimicrobial chemotherapy,
J C Pioget, and M Wolff, and E Singlas, and M J Laisne, and B Clair, and B Regnier, and F Vachon
January 1996, Neurologia i neurochirurgia polska,
Copied contents to your clipboard!